Elevated Levels of Apoptosis Regulator Proteins P53 and BCL-2 are Independent Prognostic Biomarkers in Surgically Treated Clinically Localized Prostate Cancer
Authors:
- 1 October 1996
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 156 (4) , 1511-1516
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Immunohistochemical detection of p53 protein as a prognostic indicator in prostate cancerHuman Pathology, 1995
- Bcl-2 blocks p53-dependent apoptosis.Molecular and Cellular Biology, 1994
- Cancer statistics, 1994CA: A Cancer Journal for Clinicians, 1994
- p53 Expression and Clinical Outcome in Prostate CancerBritish Journal of Urology, 1993
- An assessment of radical prostatectomy. Time trends, geographic variation, and outcomes. The Prostate Patient Outcomes Research Team1993
- Apoptotic cell death induced by c-myc is inhibited by bcl-2Nature, 1992
- The involvement of oncogenes and tumor suppressor genes in the control of apoptosisCancer and Metastasis Reviews, 1992
- Bcl-2 initiates a new category of oncogenes: regulators of cell deathBlood, 1992
- p53, guardian of the genomeNature, 1992
- Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell deathNature, 1990